Research Library
PRECLINICAL

AOD-9604

Also known as: AOD9604, hGH fragment 176-191

Metabolic SignalingPeptide Signaling
ClassificationModified synthetic fragment of human growth hormone (hGH 176-191).
Catalog / SKUAOD-9604 · MX-AOD9604-010 · 10 mg
TargetsGrowth hormone C-terminal fragment biology; Adipose/lipid metabolism (experimental)

Molecular Overview

AOD-9604 is a synthetic peptide based on the C-terminal region (residues 176-191) of human growth hormone. It has been investigated in preclinical models for its relationship to lipid and adipose metabolism, independent of the full growth-promoting activity of intact growth hormone.

Mechanistic Background

Research has characterized the hGH 176-191 fragment in the context of lipolytic/lipid-metabolism pathways in experimental models. Mechanistic details remain under investigation.

What Researchers Study

Researchers have examined its effects on adipose tissue and lipid metabolism in cell and animal models.

Evidence Landscape

Current evidence level: PRECLINICAL. Preclinical evidence does not equate to demonstrated human efficacy.

Research Limitations

Most available evidence is preclinical; robust human efficacy data are limited. Commercial preparations may differ from peptides used in published studies.

Research Use Only

Molecularix Biolabs provides research materials for legitimate laboratory research. Information in this Research Library is provided for educational and scientific reference purposes and is not medical advice, treatment guidance, or a recommendation for human or veterinary use.